Isaac S. Kohane
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Isaac S. Kohane has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Imre Solti
Department of Biomedical Informatics, Cincinnati Children’s Hospital Medical Center, Cincinnati, USA
1 shared publication - John Peter Perentesis
Division of Oncology Cancer and Blood Diseases Institute Cincinnati Children's Hospital Medical Center Cincinnati Ohio USA
1 shared publication - Jordan Wright
Cancer and Blood Disease Institute, Cincinnati Children’s Hospital Medical Center, Cincinnati, USA
1 shared publication - Louise Deléger
Université Paris-Saclay, INRAE, MaIAGE
1 shared publication - Megan Kaiser
Department of Biomedical Informatics, Cincinnati Children’s Hospital Medical Center, Cincinnati, USA
1 shared publication - Todd Lingren
Division of Biomedical Informatics Cincinnati Children's Hospital Medical Center Cincinnati, OH United States
1 shared publication
Latest Publications
- Open Access
- 14 April 2015
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 15 (1) , 1-10
Increasing the efficiency of trial-patient matching: automated clinical trial eligibility Pre-screening for pediatric oncology patients
Manual eligibility screening (ES) for a clinical trial typically requires a labor-intensive review of patient records that utilizes many resources. Leveraging state-of-the-art natural language processing (NLP) and information extraction (IE) technologies, we sought to improve the efficiency of physician decision-making in clinical trial enrollment. In order to markedly reduce the pool of potential candidates for staff screening, we developed an automated ES algorithm to identify patients who meet core eligibility characteristics of an oncology clinical trial. We collected narrative eligibility criteria from ClinicalTrials.gov for 55 clinical trials actively enrolling oncology patients in our institution between 12/01/2009 and 10/31/2011. In parallel, our ES algorithm extracted clinical and demographic information from the Electronic Health Record (EHR) data fields to represent profiles of all 215 oncology patients admitted to cancer treatment during the same period. The automated ES algorithm then matched the trial criteria with the patient profiles to identify potential trial-patient matches. Matching performance was validated on a reference set of 169 historical trial-patient enrollment decisions, and workload, precision, recall, negative predictive value (NPV) and specificity were calculated. Without automation, an oncologist would need to review 163 patients per trial on average to replicate the historical patient enrollment for each trial. This workload is reduced by 85% to 24 patients when using automated ES (precision/recall/NPV/specificity: 12.6%/100.0%/100.0%/89.9%). Without automation, an oncologist would need to review 42 trials per patient on average to replicate the patient-trial matches that occur in the retrospective data set. With automated ES this workload is reduced by 90% to four trials (precision/recall/NPV/specificity: 35.7%/100.0%/100.0%/95.5%). By leveraging NLP and IE technologies, automated ES could dramatically increase the trial screening efficiency of oncologists and enable participation of small practices, which are often left out from trial enrollment. The algorithm has the potential to significantly reduce the effort to execute clinical research at a point in time when new initiatives of the cancer care community intend to greatly expand both the access to trials and the number of available trials.
- 14 April 2015
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 15 (1) , 1-10
Open AccessIncreasing the efficiency of trial-patient matching: automated clinical trial eligibility Pre-screening for pediatric oncology patients
Manual eligibility screening (ES) for a clinical trial typically requires a labor-intensive review of patient records that utilizes many resources. Leveraging state-of-the-art natural language processing (NLP) and information extraction (IE) technologies, we sought to improve the efficiency of physician decision-making in clinical trial enrollment. In order to markedly reduce the pool of potential candidates for staff screening, we developed an automated ES algorithm to identify patients who meet core eligibility characteristics of an oncology clinical trial. We collected narrative eligibility criteria from ClinicalTrials.gov for 55 clinical trials actively enrolling oncology patients in our institution between 12/01/2009 and 10/31/2011. In parallel, our ES algorithm extracted clinical and demographic information from the Electronic Health Record (EHR) data fields to represent profiles of all 215 oncology patients admitted to cancer treatment during the same period. The automated ES algorithm then matched the trial criteria with the patient profiles to identify potential trial-patient matches. Matching performance was validated on a reference set of 169 historical trial-patient enrollment decisions, and workload, precision, recall, negative predictive value (NPV) and specificity were calculated. Without automation, an oncologist would need to review 163 patients per trial on average to replicate the historical patient enrollment for each trial. This workload is reduced by 85% to 24 patients when using automated ES (precision/recall/NPV/specificity: 12.6%/100.0%/100.0%/89.9%). Without automation, an oncologist would need to review 42 trials per patient on average to replicate the patient-trial matches that occur in the retrospective data set. With automated ES this workload is reduced by 90% to four trials (precision/recall/NPV/specificity: 35.7%/100.0%/100.0%/95.5%). By leveraging NLP and IE technologies, automated ES could dramatically increase the trial screening efficiency of oncologists and enable participation of small practices, which are often left out from trial enrollment. The algorithm has the potential to significantly reduce the effort to execute clinical research at a point in time when new initiatives of the cancer care community intend to greatly expand both the access to trials and the number of available trials.
- Open Access
- 1 March 2002
- Published by Oxford University Press (OUP) in Journal of the American Medical Informatics Association
- Vol. 9 (2) , 116-119
The Contributions of Biomedical Informatics to the Fight Against Bioterrorism
A comprehensive and timely response to current and future bioterrorist attacks requires a data acquisition, threat detection, and response infrastructure with unprecedented scope in time and space. Fortunately, biomedical informaticians have developed and implemented architectures, methodologies, and tools at the local and the regional levels that can be immediately pressed into service for the protection of our populations from these attacks. These unique contributions of the discipline of biomedical informatics are reviewed here.
- 1 March 2002
- Published by Oxford University Press (OUP) in Journal of the American Medical Informatics Association
- Vol. 9 (2) , 116-119
Open AccessThe Contributions of Biomedical Informatics to the Fight Against Bioterrorism
A comprehensive and timely response to current and future bioterrorist attacks requires a data acquisition, threat detection, and response infrastructure with unprecedented scope in time and space. Fortunately, biomedical informaticians have developed and implemented architectures, methodologies, and tools at the local and the regional levels that can be immediately pressed into service for the protection of our populations from these attacks. These unique contributions of the discipline of biomedical informatics are reviewed here.
- Open Access
- 1 September 2000
- Published by Oxford University Press (OUP) in Journal of the American Medical Informatics Association
- Vol. 7 (5) , 512-516
Bioinformatics and Clinical Informatics: The Imperative to Collaborate
In this issue, Perry Miller and Russ Altman review the experiences at Yale and Stanford that have led to a convergence and cross-pollination between clinical informatics and bioinformatics at those institutions. A related convergence is revealed by a MEDLINE search for the string “informatics” in the last five months. Of 346 publications, 175 were in the area of genomics and not clinical applications. Concurrently, there has been much discussion within the informatics community about the dual nature of the research agenda (and, not coincidentally, the funding opportunities) as it pertains to clinical applications and fundamental biological research.1,2 Informal discussions with investigators in bioinformatics and clinical informatics, however, are tinged with concern that these two disciplines in biomedical informatics will diverge or at least that the two investigator communities are not collaborating sufficiently.
- 1 September 2000
- Published by Oxford University Press (OUP) in Journal of the American Medical Informatics Association
- Vol. 7 (5) , 512-516
Open AccessBioinformatics and Clinical Informatics: The Imperative to Collaborate
In this issue, Perry Miller and Russ Altman review the experiences at Yale and Stanford that have led to a convergence and cross-pollination between clinical informatics and bioinformatics at those institutions. A related convergence is revealed by a MEDLINE search for the string “informatics” in the last five months. Of 346 publications, 175 were in the area of genomics and not clinical applications. Concurrently, there has been much discussion within the informatics community about the dual nature of the research agenda (and, not coincidentally, the funding opportunities) as it pertains to clinical applications and fundamental biological research.1,2 Informal discussions with investigators in bioinformatics and clinical informatics, however, are tinged with concern that these two disciplines in biomedical informatics will diverge or at least that the two investigator communities are not collaborating sufficiently.